{
  "id": 227230,
  "title": "Tau Protein Linked to Mitochondrial Reverse Electron Transport in Preclinical Models",
  "url": "https://urgent.news/2026/08/06/tau-protein-linked-to-mitochondrial-reverse-electron-transport-in",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-08-06T15:59:16.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/translational-medicine/tau-protein-linked-to-mitochondrial-reverse-electron-transport-in-preclinical-models/"
  },
  "original_language": "en",
  "account": "Researchers at Stanford University and the University of California, San Francisco have discovered a new mechanism linking tau protein to neurodegenerative diseases. In neurons, tau protein is usually involved in stabilizing microtubules, which are essential for proper cell function. However, when hyperphosphorylated, tau can enter mitochondria and disrupt the electron transport chain (ETC), triggering a pathological cycle of events. This newly identified reverse electron transport (RET) process produces reactive oxygen species (ROS), leading to inflammation and damage to proteins. The study, published in Neuron, reveals that RET may serve as a common pathogenic mechanism in tauopathies, including Alzheimer's, Parkinson's, and Huntington's diseases. The findings suggest that targeting RET could be a novel therapeutic approach to counteract the detrimental effects of tau abnormalities in these diseases.",
  "summary": "A recent study by researchers at Stanford University School of Medicine and the University of California, San Francisco has discovered that the protein tau, previously linked to neurodegenerative disorders such as Alzheimer's disease, may actually cause these disorders through a novel mechanism. The study found that phosphorylated tau can enter mitochondria, interfering with the electron transport chain and triggering reverse electron transport, leading to further deterioration of mitochondrial function. This discovery suggests that RET may serve as a common pathogenic mechanism linking tau abnormalities to mitochondrial dysfunction across various diseases, potentially offering new therapeutic interventions for tauopathies.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}